Calibre Chemicals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 6.84 Cr
- Company Age 41 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 259.10 Cr
- Satisfied Charges ₹ 76.99 Cr
- Revenue Growth 65.52%
- Profit Growth 45.74%
- Ebitda 37.80%
- Net Worth 33.55%
- Total Assets 49.53%
About Calibre Chemicals
Calibre Chemicals Private Limited (CCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 October 1983 and has a history of 41 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Bhavnani Chemicals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 6.84 Cr.
The company currently has active open charges totaling ₹259.10 Cr. The company has closed loans amounting to ₹76.99 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Calibre Chemicals Private Limited India are Deepak Chander as Ceo, Rohit Dhanuka as Cfo, and Sherry Jain as Company Secretary. Vijay Rai, Raman Ramachandran, Vishal Sharma, and Four other members serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100MH1983PTC031128
-
Company No.
031128
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Oct 1983
-
Date of AGM
04 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Calibre Chemicals Private Limited offer?
Calibre Chemicals Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Nervous System and Antipsychotic API, Industrial Chemicals, Chemical Reagents & Catalysts, Potassium Salts, Iodine Compounds, Oxidizing Agent, Cosmetics, Hair & Beauty Products, Cosmetic Chemical, Industrial Chemicals & Supplies.
Who are the key members and board of directors at Calibre Chemicals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Chander
|
CEO | 17-Jun-2019 | Current |
| Rohit Dhanuka | CFO | 02-Aug-2021 | Current |
| Sherry Jain | Company Secretary | 22-Jun-2022 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Vishal Sharma
|
Nominee Director | 26-Aug-2021 | Current |
|
Vijay Rai
|
Director | 01-Jul-2019 | Current |
|
Vibhor Talreja
|
Nominee Director | 26-Aug-2021 | Current |
|
Rikhil Bhavnani
|
Director | 01-Oct-2022 | Current |
|
Raman Ramachandran
|
Director | 28-Jan-2022 | Current |
|
Rajesh Dahiya
|
Nominee Director | 10-Jan-2023 | Current |
Financial Performance of Calibre Chemicals.
Calibre Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 65.52% increase. The company also saw a substantial improvement in profitability, with a 45.74% increase in profit. The company's net worth Soared by an impressive increase of 33.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Calibre Chemicals?
In 2023, Calibre Chemicals had a promoter holding of 81.94% and a public holding of 18.06%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Transhealth Private LimitedVishal Sharma is a mutual person
-
Pimex India Private LimitedVijay Rai is a mutual person
-
Softgel Healthcare Private LimitedVishal Sharma is a mutual person
-
Compossible Umwelten Private LimitedTrivik Bhavnani is a mutual person
-
Calimara Matters Private LimitedRohit Dhanuka and Sherry Jain are mutual person
-
Max Life Insurance Company LimitedRajesh Dahiya is a mutual person
Charges (Loans)
₹259.10 Cr
₹76.99 Cr
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 105.00 Cr
- Others : 80.00 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 74.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2022 | Others | ₹80.00 Cr | Open |
| 24 Feb 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹74.10 Cr | Open |
| 27 Nov 2004 | Citi Bank N.A. | ₹105.00 Cr | Open |
| 19 Feb 2010 | State Bank Of India | ₹19.00 Cr | Satisfied |
| 13 Jul 2008 | Citibank N.A. | ₹3.50 Cr | Satisfied |
How Many Employees Work at Calibre Chemicals?
Calibre Chemicals has a workforce of 123 employees as of May 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Calibre Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Calibre Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
